BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35855704)

  • 1. Study of angiogenesis in invasive breast carcinoma by morphometry and immunohistochemistry.
    Bhatia JK; Chaudhary T; Boruah D; Bharadwaj R
    Med J Armed Forces India; 2022 Jul; 78(3):345-354. PubMed ID: 35855704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of microvessel parameters in invasive ductal carcinoma of the breast and fibroadenomas: a morphometric study.
    Boruah D; Bhatia JK; Rai A; Srinivas V; Nijhawan VS
    Ann Diagn Pathol; 2016 Dec; 25():72-78. PubMed ID: 27806851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphometric study of nuclei and microvessels in gliomas and its correlation with grades.
    Boruah D; Deb P; Srinivas V; Mani NS
    Microvasc Res; 2014 May; 93():52-61. PubMed ID: 24657905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
    Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
    Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas.
    Netto GC; Bleil CB; Hilbig A; Coutinho LM
    Neuropathology; 2008 Feb; 28(1):17-23. PubMed ID: 18181830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions.
    Ding S; Li C; Lin S; Yang Y; Liu D; Han Y; Zhang Y; Li L; Zhou L; Kumar S
    Hum Pathol; 2006 Jul; 37(7):861-6. PubMed ID: 16784986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microvessel density assessment in benign and malignant endometrial changes.
    Czekierdowski A; Czekierdowska S; Czuba B; Cnota W; Sodowski K; Kotarski J; Zwirska-Korczala K
    J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():45-51. PubMed ID: 18955753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.
    Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y
    Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphometric study of microvessels in primary CNS tumors and its correlation with tumor types and grade.
    Deb P; Boruah D; Dutta V
    Microvasc Res; 2012 Jul; 84(1):34-43. PubMed ID: 22465694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma.
    Raica M; Cimpean AM; Anghel A
    Neoplasma; 2007; 54(4):278-84. PubMed ID: 17822316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma.
    Yang LY; Lu WQ; Huang GW; Wang W
    BMC Cancer; 2006 May; 6():110. PubMed ID: 16650286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of microvessel density quantified through the immunohistochemistry expression of CD34 and CD105 in rectal cancer.
    Goldiş DS; Sferdian MF; Tarţă C; Fulger LO; Totolici BD; Neamţu C
    Rom J Morphol Embryol; 2015; 56(2):419-24. PubMed ID: 26193208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The associations between serum VEGF, bFGF and endoglin levels with microvessel density and expression of proangiogenic factors in malignant and benign ovarian tumors.
    Szubert S; Moszynski R; Michalak S; Nowicki M; Sajdak S; Szpurek D
    Microvasc Res; 2016 Sep; 107():91-6. PubMed ID: 27312585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas.
    Barresi V; Cerasoli S; Vitarelli E; Tuccari G
    Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma].
    Li Q; Zhang B; Peng P
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between selected angiogenic markers and prognosis in pediatric adrenocortical tumors: Angiogenic markers and prognosis in pediatric ACTs.
    Dias AI; Fachin CG; Avó LR; Frazão CV; Caran EM; Schettini ST; Alves MT; Ribeiro RC; Abib Sde C
    J Pediatr Surg; 2015 Aug; 50(8):1323-8. PubMed ID: 25783314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy.
    Miyata Y; Mitsunari K; Asai A; Takehara K; Mochizuki Y; Sakai H
    Prostate; 2015 Jan; 75(1):84-91. PubMed ID: 25307287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34.
    Miyata Y; Sagara Y; Watanabe S; Asai A; Matsuo T; Ohba K; Hayashi T; Sakai H
    Virchows Arch; 2013 Nov; 463(5):673-9. PubMed ID: 23975255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression.
    Paschoal JP; Bernardo V; Canedo NH; Ribeiro OD; Caroli-Bottino A; Pannain VL
    BMC Cancer; 2014 Feb; 14():72. PubMed ID: 24507660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between expression of CD105 and growth factors in malignant tumors of gastrointestinal tract and its significance.
    Yu JX; Zhang XT; Liao YQ; Zhang QY; Chen H; Lin M; Kumar S
    World J Gastroenterol; 2003 Dec; 9(12):2866-9. PubMed ID: 14669355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.